Literature DB >> 21725358

The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.

C H Benes1, G Poulogiannis, L C Cantley, S P Soltoff.   

Abstract

Multiple SRC-family kinases (SFKs) are commonly activated in carcinoma and appear to have a role in metastasis through incompletely understood mechanisms. Recent studies have shown that CDCP1 (CUB (complement C1r/C1s, Uegf, Bmp1) Domain-Containing Protein-1) is a transmembrane protein and an SRC substrate potentially involved in metastasis. Here we show that increased SFK and CDCP1 tyrosine phosphorylation is, surprisingly, associated with a decrease in FAK phosphorylation. This appears to be true in human tumors as shown by our correlation analysis of a mass spectrometric data set of affinity-purified phosphotyrosine peptides obtained from normal and cancer lung tissue samples. Induction of tyrosine phosphorylation of CDCP1 in cell culture, including by a mAb that binds to its extracellular domain, promoted changes in SFK and FAK tyrosine phosphorylation, as well as in PKC(TM), a protein known to associate with CDCP1, and these changes are accompanied by increases in adhesion and motility. Thus, signaling events that accompany the CDCP1 tyrosine phosphorylation observed in cell lines and human lung tumors may explain how the CDCP1/SFK complex regulates motility and adhesion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21725358      PMCID: PMC3777806          DOI: 10.1038/onc.2011.262

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  52 in total

1.  The transmembrane src substrate Trask is an epithelial protein that signals during anchorage deprivation.

Authors:  Danislav S Spassov; Frederick L Baehner; Ching Hang Wong; Stephen McDonough; Mark M Moasser
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

Review 2.  A mechanism for SRC kinase-dependent signaling by noncatalytic receptors.

Authors:  Jonathan A Cooper; Hong Qian
Journal:  Biochemistry       Date:  2008-04-30       Impact factor: 3.162

Review 3.  Integrin-regulated FAK-Src signaling in normal and cancer cells.

Authors:  Satyajit K Mitra; David D Schlaepfer
Journal:  Curr Opin Cell Biol       Date:  2006-08-17       Impact factor: 8.382

4.  Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdelta.

Authors:  Yaowu He; Andreas Wortmann; Les J Burke; Janet C Reid; Mark N Adams; Ibtissam Abdul-Jabbar; James P Quigley; Richard Leduc; Daniel Kirchhofer; John D Hooper
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

Review 5.  Src in cancer: deregulation and consequences for cell behaviour.

Authors:  Margaret C Frame
Journal:  Biochim Biophys Acta       Date:  2002-06-21

Review 6.  The cell surface glycoprotein CDCP1 in cancer--insights, opportunities, and challenges.

Authors:  Andreas Wortmann; Yaowu He; Elena I Deryugina; James P Quigley; John D Hooper
Journal:  IUBMB Life       Date:  2009-07       Impact factor: 3.885

7.  Shc proteins are phosphorylated and regulated by the v-Src and v-Fps protein-tyrosine kinases.

Authors:  J McGlade; A Cheng; G Pelicci; P G Pelicci; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

8.  CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.

Authors:  Takamasa Uekita; Lin Jia; Mako Narisawa-Saito; Jun Yokota; Tohru Kiyono; Ryuichi Sakai
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

9.  Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.

Authors:  M S Talamonti; M S Roh; S A Curley; G E Gallick
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

10.  Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.

Authors:  Klarisa Rikova; Ailan Guo; Qingfu Zeng; Anthony Possemato; Jian Yu; Herbert Haack; Julie Nardone; Kimberly Lee; Cynthia Reeves; Yu Li; Yerong Hu; Zhiping Tan; Matthew Stokes; Laura Sullivan; Jeffrey Mitchell; Randy Wetzel; Joan Macneill; Jian Min Ren; Jin Yuan; Corey E Bakalarski; Judit Villen; Jon M Kornhauser; Bradley Smith; Daiqiang Li; Xinmin Zhou; Steven P Gygi; Ting-Lei Gu; Roberto D Polakiewicz; John Rush; Michael J Comb
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

View more
  19 in total

1.  CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer.

Authors:  H J Wright; J Arulmoli; M Motazedi; L J Nelson; F S Heinemann; L A Flanagan; O V Razorenova
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

2.  The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration.

Authors:  Ying Dong; Yaowu He; Leonore de Boer; M Sharon Stack; John W Lumley; Judith A Clements; John D Hooper
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

3.  CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.

Authors:  Heather J Wright; Jue Hou; Binzhi Xu; Marvin Cortez; Eric O Potma; Bruce J Tromberg; Olga V Razorenova
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

4.  Regulation of inside-out β1-integrin activation by CDCP1.

Authors:  Sara G Pollan; Fangjin Huang; Jamie M Sperger; Joshua M Lang; Colm Morrissey; Anne E Cress; C Y Chu; Neil A Bhowmick; Sungyong You; Michael R Freeman; Danislav S Spassov; Mark M Moasser; William G Carter; Shakti Ranjan Satapathy; Kavita Shah; Beatrice S Knudsen
Journal:  Oncogene       Date:  2018-03-07       Impact factor: 9.867

5.  Src Kinase Is Biphosphorylated at Y416/Y527 and Activates the CUB-Domain Containing Protein 1/Protein Kinase C δ Pathway in a Subset of Triple-Negative Breast Cancers.

Authors:  Luke J Nelson; Heather J Wright; Nguyen B Dinh; Kevin D Nguyen; Olga V Razorenova; F Scott Heinemann
Journal:  Am J Pathol       Date:  2019-12-13       Impact factor: 4.307

6.  Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms.

Authors:  M E Law; P E Corsino; S C Jahn; B J Davis; S Chen; B Patel; K Pham; J Lu; B Sheppard; P Nørgaard; J Hong; P Higgins; J-S Kim; H Luesch; B K Law
Journal:  Oncogene       Date:  2012-04-30       Impact factor: 9.867

7.  Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells.

Authors:  B Casar; Y He; M Iconomou; J D Hooper; J P Quigley; E I Deryugina
Journal:  Oncogene       Date:  2011-12-19       Impact factor: 9.867

8.  Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients.

Authors:  Brooke M Emerling; Cyril H Benes; George Poulogiannis; Eric L Bell; Kevin Courtney; Hui Liu; Rayman Choo-Wing; Gary Bellinger; Kazumi S Tsukazawa; Victoria Brown; Sabina Signoretti; Stephen P Soltoff; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-01       Impact factor: 11.205

9.  In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.

Authors:  B Casar; I Rimann; H Kato; S J Shattil; J P Quigley; E I Deryugina
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

10.  Structural requirements for cub domain containing protein 1 (CDCP1) and Src dependent cell transformation.

Authors:  Gwendlyn Kollmorgen; Birgit Bossenmaier; Gerhard Niederfellner; Hans-Ulrich Häring; Reiner Lammers
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.